Non-anticoagulant versions of aPC are currently in clinical trials for ischemic stroke in combination with tPA, wound healing and retinal injury whereas sepsis and acute lung injury are not subject for current clinical studies8. The gene discussed is PLAT; the disease is ischemic stroke.